EquityAug 21 2017

Investing in equity: Specialist sectors

pfs-logo
cisi-logo
CPD
Approx.60min
  • Learn how technology is changing the outlook for global equities
  • Understand the debate over the future for the pharmaceutical and biotechnology sectors
  • Grasp why insurers could overtake banks as the preferred financial stock

Investing in equity: Specialist sectors

  • Learn how technology is changing the outlook for global equities
  • Understand the debate over the future for the pharmaceutical and biotechnology sectors
  • Grasp why insurers could overtake banks as the preferred financial stock
pfs-logo
cisi-logo
CPD
Approx.60min
Search supported by

Introduction

By Taha Lokhandwala
twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon

Three sectors dominate the global equity environment, accounting for almost half the entire market. The size and complexity of the technology, healthcare and financials sectors has meant fund firms have invested heavily in offering focused funds and strategies.

Fund buyers and portfolio managers can use such products to create their own equity biases for clients, but must remain aware of volatility and overall diversification.

This special report focuses on questions such as: What should buyers consider when creating a more focused global equity strategy? While technology stocks have led the way in 2017 - where do future returns lie?

In healthcare, are traditional pharma stocks expected to grow with their drug pipelines, or will they need to buy younger firms in order to succeed?

And in financials, are banks really set to return to form in the macro environment, or will they remain in the shadows of their insurance peers?